New study aims to predict and prevent dangerous drug reactions
NCT ID NCT06822959
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether combining genetic tests, regular drug level checks, and careful medication reviews can help doctors prescribe the right drugs and avoid harmful side effects. It involves 450 adults with cancer and children with chronic inflammatory diseases. The goal is to create a safer, more personalized way to manage medications that could be used across the country.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG REACTION (ADR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro di Riferimento Oncologico di Aviano (CRO)
Aviano, Pordenone, 33081, Italy
-
IRCCS materno infantile Burlo Garofolo di Trieste
Trieste, Trieste, 34137, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?